Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo

被引:108
|
作者
Nakajima, Yoshimi [1 ]
Inokuchi, Yuta [1 ]
Shimazawa, Masamitsu [1 ]
Otsubo, Kazumasa [2 ]
Ishibashi, Takashi [3 ]
Hara, Hideaki [1 ]
机构
[1] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu 5028585, Japan
[2] Asahi Kasei Pharma Corp, Fine Chem Div, Fine Chem Mkt Dept, Tokyo 1018481, Japan
[3] Nippon Oil Corp, Merchandise Business Dept, Biotechnol Business Sect, Tokyo 1058412, Japan
关键词
D O I
10.1211/jpp/60.10.0013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have investigated whether astaxanthin exerted neuroprotective effects in retinal ganglion cells in-vitro and in-vivo. In-vitro, retinal damage was induced by 24-h hydrogen peroxide (H2O2) exposure or serum deprivation, and cell viability was measured using a WST assay. In cultured retinal ganglion cells (RGC-5, a rat ganglion cell-line transformed using E1A virus), astaxanthin inhibited the neurotoxicity induced by H2O2 or serum deprivation, and reduced the intracellular oxidation induced by various reactive oxygen species (ROS). Furthermore, astaxanthin decreased the radical generation induced by serum deprivation in RGC-5. In mice in-vivo, astaxanthin (100 mg kg(-1), p.o., four times) reduced the retinal damage (a decrease in retinal ganglion cells and in thickness of inner plexiform layer) induced by intravitreal N-methyl-D-aspartate (NMDA) injection. Furthermore, astaxanthin reduced the expressions of 4-hydroxy-2-nonenal (4-HNE)-modified protein (indicator of lipid peroxidation) and 8-hydroxy-deoxyguanosine (8-OHdG; indicator of oxidative DNA damage). These findings indicated that astaxanthin had neuroprotective effects against retinal damage in-vitro and in-vivo, and that its protective effects may have been partly mediated via its antioxidant effects.
引用
收藏
页码:1365 / 1374
页数:10
相关论文
共 50 条
  • [41] FUNCTIONAL ACTIVATION OF CORNEAL LANGERHANS CELLS IN-VITRO AND IN-VIVO
    CHOUDHURY, A
    PAKALNIS, VA
    TRIPATHI, RC
    BOWERS, WE
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1877 - 1877
  • [42] IN-VIVO AND IN-VITRO PHAGOCYTOSIS OF LATEX PARTICLES BY PERITONEAL CELLS
    BURK, KH
    BERLIN, JD
    TEXAS REPORTS ON BIOLOGY AND MEDICINE, 1971, 29 (03) : 418 - &
  • [43] POLYCATION-TREATED TUMOR CELLS IN-VIVO AND IN-VITRO
    MOROSON, H
    CANCER RESEARCH, 1971, 31 (03) : 373 - &
  • [44] INTERNALIZATION OF MICROBUBBLES BY TUMOR-CELLS IN-VIVO AND IN-VITRO
    BARBARESE, E
    HO, SY
    DARRIGO, JS
    SIMON, RH
    JOURNAL OF NEURO-ONCOLOGY, 1995, 26 (01) : 25 - 34
  • [45] FUNCTIONAL ACTIVATION OF CORNEAL LANGERHANS CELLS IN-VITRO AND IN-VIVO
    BOWERS, WE
    ALPAKALNIS, V
    CHOUDHURY, A
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 9 - 9
  • [47] IN-VITRO AND IN-VIVO EFFECTS OF ENDOTOXIN ON MOUSE PERITONEAL CELLS
    SHANDS, JW
    PEAVY, DL
    GORMUS, BJ
    MCGRAW, J
    INFECTION AND IMMUNITY, 1974, 9 (01) : 106 - 112
  • [48] PRODUCTION OF ERYTHROPOIETIN BY LIVER-CELLS IN-VIVO AND IN-VITRO
    ECKARDT, KU
    PUGH, CW
    MEIER, M
    TAN, CC
    RATCLIFFE, PJ
    KURTZ, A
    MOLECULAR, CELLULAR, AND DEVELOPMENTAL BIOLOGY OF ERYTHROPOIETIN AND ERYTHROPOIESIS, 1994, 718 : 50 - 63
  • [49] ACTION OF POLYCATIONS ON TUMOR-CELLS IN-VIVO AND IN-VITRO
    MOROSON, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1971, 12 (NMAR): : 43 - &
  • [50] IN-VITRO AND IN-VIVO ACTIVITIES OF SPARFLOXACIN AGAINST MYCOPLASMA-PNEUMONIAE
    KAKU, M
    ISHIDA, K
    IRIFUNE, K
    MIZUKANE, R
    TAKEMURA, H
    YOSHIDA, R
    TANAKA, H
    USUI, T
    TOMONO, K
    SUYAMA, N
    KOGA, H
    KOHNO, S
    HARA, K
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) : 738 - 741